Thus, BRAFV600E-dependent TFEB phosphorylation and TGF-β activation enhances tumor aggressiveness (Supplementary Fig. 12), as observed in BRAF-mutant melanoma patients50,51. This evidence concerns the gene TGFB1 and melanoma.